ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 187 filers reported holding ACORDA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $2,295,000 | -64.6% | 799,630 | -5.3% | 0.01% | -64.0% |
| Q2 2019 | $6,478,000 | -32.6% | 844,580 | +16.8% | 0.02% | -34.2% |
| Q1 2019 | $9,606,000 | +18.8% | 722,829 | +39.2% | 0.04% | +2.7% |
| Q4 2018 | $8,087,000 | -19.8% | 519,093 | +1.1% | 0.04% | -2.6% |
| Q3 2018 | $10,088,000 | +7.1% | 513,399 | +56.5% | 0.04% | -5.0% |
| Q2 2018 | $9,418,000 | +7.0% | 328,143 | -11.8% | 0.04% | -2.4% |
| Q1 2018 | $8,800,000 | -62.4% | 372,077 | -45.7% | 0.04% | -68.5% |
| Q3 2013 | $23,415,000 | +4.8% | 684,651 | +1.1% | 0.13% | -2.3% |
| Q2 2013 | $22,337,000 | – | 677,097 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |